Re: Jbog Msg #1213. In addition to Pfizer, SGP, Immunogen, and Merck (USA) have anti-Igfr antibodies in the works. All the more reason for Imclone to partner and move forward with development of their anti-IGFR antibody. Here are some links if anyone is interested.
Schering Plough (I think that this is a Medarex AB) Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.